Jonathan Pritchard (center) and his colleagues, Yang Li (left) and Evan Boyle, discuss their recent work positing that almost any gene can influence disease.
Steve Fisch
Thousands of genes influence most diseases
In a provocative new perspective piece, Stanford researchers say that disease genes are spread uniformly across the genome, not clustered in specific molecular pathways, as has been thought.
A core assumption in the study of disease-causing genes has been that they are clustered in molecular pathways directly connected to the disease. But work by a group of researchers at the Stanford University School of Medicine suggests otherwise.
The gene activity of cells is so broadly networked that virtually any gene can influence disease, the researchers found. As a result, most of the heritability of diseases is due not to a handful of core genes, but to tiny contributions from vast numbers of peripheral genes that function outside disease pathways.
Any given trait, it seems, is not controlled by a small set of genes. Instead, nearly every gene in the genome influences everything about us. The effects may be tiny, but they add up.
The work is described in a paper published June 15 in Cell. Jonathan Pritchard, PhD, professor of genetics and of biology, is the senior author. Graduate student Evan Boyle and postdoctoral scholar Yang Li, PhD, share lead authorship.
The researchers call their provocative new understanding of disease genes an “omnigenic model” to indicate that almost any gene can influence diseases and other complex traits. In any cell, there might be 50 to 100 core genes with direct effects on a given trait, as well as easily another 10,000 peripheral genes that are expressed in the same cell with indirect effects on that trait, said Pritchard, who is also a Howard Hughes Medical Institute investigator.
Each of the peripheral genes has a small effect on the trait. But because those thousands of genes outnumber the core genes by orders of magnitude, most of the genetic variation related to diseases and other traits comes from the thousands of peripheral genes. So, ironically, the genes whose impact on disease is most indirect and small end up being responsible for most of the inheritance patterns of the disease.
“This is a compelling paper that presents a plausible and fascinating model to explain a number of confusing observations from genomewide studies of disease,” said Joe Pickrell, PhD, an investigator at the New York Genome Center, who was not involved in the work.
From a polygenic to omnigenic model
Until recently, said Pritchard, he thought of genetically complex traits as conforming to a polygenic model, in which each gene has a direct effect on a trait, whether that trait is something like height or a disease, such as autism.
Jonathan Pritchard
But last year, while putting together a paper on the recent evolution of height in northern Europeans, Pritchard was forced to rethink that idea.
In the earlier work on the genetics of height, Pritchard and his colleagues were surprised to find that essentially the entire genome influenced height. “It was really unintuitive to me,” he said. “To be honest, I thought that it was probably wrong.” His team spent a long time trying to understand the surprising result.
Instead, he said, “I gradually started to realize that the data don’t really fit the polygenic model.” That work led directly to the current Cell paper, he said. “We started to think, ‘If the whole genome is involved in a complex trait like height, then how does that work?’”
Therapeutic implications
The polygenic model leads researchers to focus on the short list of core genes that function in molecular pathways known to impact diseases. So, therapeutic research typically means addressing those core genes. A common approach to gene discovery is to do larger and larger genomewide association studies, the paper notes, but Pritchard’s team argues against this approach because the sample sizes are expensive and the thousands of peripheral genes uncovered are likely to have tiny, indirect effects. “After you get the first 100 hits,” said Pritchard, “you’ve probably found most of the core genes you’re going to get through genomewide association studies.”
Instead, he recommends switching to deep sequencing the core genes to hunt down rare variants that might have bigger effects. For clinical use, Pritchard said, there’s still a rationale for genomewide association studies: to predict the peripheral gene-based risk factors in individual patients in order to personalize medicine.
Implications for basic science
Pritchard’s omnigenic model promises to take basic biology in new directions and means biologists need to think a lot more about the structure of networks that link together those thousands of peripheral disease genes.
“If this model is right,” said Pritchard, “it’s telling us something profound about how cells work that we don’t really understand very well. And so maybe that puts us a little bit further away from using genomewide association studies for therapeutics. But in terms of understanding how genetics encodes disease risk, it’s really important to understand.”
Learn more:Thousands of genes influence most diseases
The Latest on: Disease genes
December 10, 2018 - Developmental Disorder, Other Disease Genes Revealed by Mapping Regions Resistant to Change GenomeWebResearchers used exome data for more than 123000 individuals to map "constrained coding regions," where disease-related variants are over-represented.
Big datasets pinpoint new regions to explore the genome for disease - EurekAlert
December 10, 2018 - Big datasets pinpoint new regions to explore the genome for disease EurekAlertImagine rain falling on a square of sidewalk. While the raindrops appear to land randomly, over time a patch of sidewalk somehow remains dry. The emerging ...New approach will help geneticists identify genes responsible for complex traits - Medical Xpress
December 17, 2018 - New approach will help geneticists identify genes responsible for complex traits Medical XpressIn biomedical research, plant breeding, and countless other endeavors, geneticists are on the hunt for the specific genes responsible for disease susceptibility, ...
Engineering bacteria to treat genetic diseases - Medical Xpress
November 27, 2018 - Engineering bacteria to treat genetic diseases Medical XpressA pill containing millions of bacteria ready to colonize your gut might be a nightmare to many. But it may become an effective new tool for fighting disease.
Medical Detectives: The Last Hope For Families Coping With Rare Diseases - wgbh.org
December 17, 2018 - Medical Detectives: The Last Hope For Families Coping With Rare Diseases wgbh.orgAll over the country, specialized teams of doctors are giving hope to families who are desperately searching for a diagnosis. The medical sleuths, scattered ...
For disease risk, is it genes or the environment? Probably both. - HSPH News
December 14, 2018 - For disease risk, is it genes or the environment? Probably both. HSPH NewsDecember 14, 2018 – It's a question that has long intrigued epidemiologists: How much of a role do genes play in the onset of diseases and how much of a role ...New method for studying gene expression could improve understanding of brain disease - Science Daily
November 27, 2018 - New method for studying gene expression could improve understanding of brain disease Science DailyBy analyzing gene expression patterns, researchers have identified previously unknown distinctions between mouse and human neurons. They have also ...In the developing brain, scientists find roots of neuropsychiatric diseases - Science Daily
December 13, 2018 - In the developing brain, scientists find roots of neuropsychiatric diseases Science DailyThe most comprehensive genomic analysis of the human brain ever undertaken has revealed new insights into the changes it undergoes through development, ...
What Is the SCA7 Disease? Why Scientists May Be One Step Closer to a Cure - Inverse
December 8, 2018 - What Is the SCA7 Disease? Why Scientists May Be One Step Closer to a Cure InverseDesigner therapies are treatments tailored to a specific disease, and nowhere is the need greater for new therapies than in a group of nervous system disorders, ...
One type of brain cell may invite Alzheimer's - Medical Xpress
December 17, 2018 - One type of brain cell may invite Alzheimer's Medical XpressBetter tactics for detecting, preventing and treating Alzheimer's disease depend on a clearer understanding of cellular-level changes in the minds of patients, ...
- For disease risk, is it genes or the environment? Probably both. on December 14, 2018 at 8:40 am
December 14, 2018 – It’s a question that has long intrigued epidemiologists: How much of a role do genes play in the onset of diseases and how much of a role does an individual’s environment play? “It ... […]
- Can gene therapy offer a cure for sickle-cell disease? on December 14, 2018 at 5:56 am
[I]n November, six months after [21-year-old Manny] Johnson became the first patient to receive an experimental therapy aimed at curing his [sickle cell] disease, the port that had become part of ... […]
- Genetic testing plus IVF can sidestep genetic disease and reduce the need for high-priced therapies on December 14, 2018 at 1:43 am
Spinal muscular atrophy type 1 (SMA) begins when a parent notices that her infant can’t lift his head, a key milestone in early development. It ends with the silent passing of a toddler, his body lack... […]
- UMMS licenses clinical-stage gene therapies for Tay-Sachs, similar diseases to Axovant on December 13, 2018 at 2:11 pm
Axovant Sciences, a Swiss company developing innovative gene therapies for serious neurological diseases, has licensed exclusive worldwide rights for the development and commercialization of two novel ... […]
- Scientists discover genetic ‘missing links’ underlying mechanism of psychiatric diseases on December 13, 2018 at 11:36 am
Dr. Daniel Geschwind is a senior author of two of 10 new studies that provide comprehensive data on the molecular workings of the brain. Since the completion of the groundbreaking Human Genome Project ... […]
- Targeting 'bubble baby' disease, this gene therapy company is planting a flag in the East Bay on December 13, 2018 at 11:18 am
Eyeing a permanent fix for "bubble baby" disease and other rare genetic conditions, a London-based gene therapy company will open a big manufacturing facility in the East Bay. The plan by Orchard Ther... […]
- Gene therapies could transform sickle cell disease into a curable illness on December 13, 2018 at 6:28 am
Manny Johnson keeps catching himself rubbing a spot on the upper right side of his chest. Starting when he was a teenager, the 21-year-old from Boston depended on a port implanted there to ease his mo... […]
- Big datasets pinpoint new regions to explore the genome for disease on December 10, 2018 at 8:03 am
Researchers use the analogy of raindrops on the sidewalk to explain their new method to identify genetic variations that cause severe pediatric diseases. Credit: University of Utah Health Imagine ... […]
- Scientists May Have Halted Blindness Caused by This Rare Genetic Disease on December 8, 2018 at 1:22 pm
Designer therapies are treatments tailored to a specific disease, and nowhere is the need greater for new therapies than in a group of nervous system disorders, known as “neurodegenerative diseases.” ... […]
- Scientists cut main heart disease risk locus out of DNA by genome editing on December 8, 2018 at 10:22 am
Scientists have made a major breakthrough in unveiling the major genetic risk factor for heart disease by precisely cutting the DNA culprit from the genome, which prevents blood vessel cell abnormalit... […]
via Google News and Bing News